Literature DB >> 35418638

European patent protection for medical uses of known products and drug repurposing.

Mateo Aboy1, Kathleen Liddell2, Matthew Jordan2, Cristina Crespo2, Johnathon Liddicoat2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35418638     DOI： 10.1038/s41587-022-01269-3

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  Drug repositioning: identifying and developing new uses for existing drugs.

Authors:  Ted T Ashburn; Karl B Thor
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

2.  Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Authors:  Mateo Aboy; Cristina Crespo; Kathleen Liddell; Johnathon Liddicoat; Matthew Jordan
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

3.  Overcoming the legal and regulatory barriers to drug repurposing.

Authors:  Alasdair Breckenridge; Robin Jacob
Journal:  Nat Rev Drug Discov       Date:  2018-06-08       Impact factor: 84.694

4.  The Reporting Items for Patent Landscapes statement.

Authors:  James A Smith; Zeeshaan Arshad; Anthony Trippe; Gary S Collins; David A Brindley; Andrew J Carr
Journal:  Nat Biotechnol       Date:  2018-11-09       Impact factor: 54.908

5.  Patent landscaping for life sciences innovation: toward consistent and transparent practices.

Authors:  Tania Bubela; E Richard Gold; Gregory D Graff; Daniel R Cahoy; Dianne Nicol; David Castle
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

6.  Myriad's impact on gene patents.

Authors:  Mateo Aboy; Kathleen Liddell; Johnathon Liddicoat; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

7.  After Myriad, what makes a gene patent claim 'markedly different' from nature?

Authors:  Mateo Aboy; Johnathon Liddicoat; Kathleen Liddell; Matthew Jordan; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

8.  Mapping the European patent landscape for medical uses of known products.

Authors:  Mateo Aboy; Kathleen Liddell; Johnathon Liddicoat; Cristina Crespo; Matthew Jordan
Journal:  Nat Biotechnol       Date:  2021-11       Impact factor: 54.908

Review 9.  Drug repurposing: progress, challenges and recommendations.

Authors:  Sudeep Pushpakom; Francesco Iorio; Patrick A Eyers; K Jane Escott; Shirley Hopper; Andrew Wells; Andrew Doig; Tim Guilliams; Joanna Latimer; Christine McNamee; Alan Norris; Philippe Sanseau; David Cavalla; Munir Pirmohamed
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.